Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-012994
Filing Date
2024-11-22
Accepted
2024-11-22 12:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27711
2 filename2.txt TEXT-EXTRACT 1191
  Complete submission text file 0000000000-24-012994.txt   40401
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filed for) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283212
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)